drugset / Trial / NCT07055321
A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
This first-in-human study is designed to evaluate the safety, tolerability, pharmacokinetics and target engagement of ETH47 in healthy participants following single intranasal and single inhaled administration
Timeline
- Start
- 2023-11-29
- Primary completion
- 2024-07-08
- Completion
- 2024-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ETH47 | Unknown | — | Intranasal |
Indications
No indication recorded.